| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |